Success Metrics

Clinical Success Rate
84.4%

Based on 593 completed trials

Completion Rate
84%(593/703)
Active Trials
262(21%)
Results Posted
41%(246 trials)
Terminated
110(9%)

Phase Distribution

Ph early_phase_1
7
1%
Ph phase_2
178
15%
Ph phase_3
123
10%
Ph not_applicable
680
56%
Ph phase_1
42
3%
Ph phase_4
85
7%

Phase Distribution

49

Early Stage

178

Mid Stage

208

Late Stage

Phase Distribution1115 total trials
Early Phase 1First-in-human
7(0.6%)
Phase 1Safety & dosage
42(3.8%)
Phase 2Efficacy & side effects
178(16.0%)
Phase 3Large-scale testing
123(11.0%)
Phase 4Post-market surveillance
85(7.6%)
N/ANon-phased studies
680(61.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.1%

593 of 769 finished

Non-Completion Rate

22.9%

176 ended early

Currently Active

262

trials recruiting

Total Trials

1,222

all time

Status Distribution
Active(338)
Completed(593)
Terminated(176)
Other(115)

Detailed Status

Completed593
Recruiting196
unknown114
Terminated110
Withdrawn66
Active, not recruiting66

Development Timeline

Analytics

Development Status

Total Trials
1222
Active
262
Success Rate
84.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 17 (0.6%)
Phase 142 (3.8%)
Phase 2178 (16.0%)
Phase 3123 (11.0%)
Phase 485 (7.6%)
N/A680 (61.0%)

Trials by Status

not_yet_recruiting645%
suspended10%
unknown1149%
recruiting19616%
completed59349%
enrolling_by_invitation121%
terminated1109%
withdrawn665%
active_not_recruiting665%

Recent Activity

Clinical Trials (1,222)

Showing 20 of 1,222 trialsScroll for more
NCT07194070

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Recruiting
NCT06367257Not Applicable

App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

Recruiting
NCT05754658

African Cancer Genome: GMD

Completed
NCT06790342Phase 3

Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya

Not Yet Recruiting
NCT04057339Not Applicable

The Influence of Time-Restricted Eating in Patients With Metabolic Syndrome

Completed
NCT07256392Phase 3

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Enrolling By Invitation
NCT07733193Phase 3

Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases.

Not Yet Recruiting
NCT05680818Phase 3

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Active Not Recruiting
NCT06847438Not Applicable

Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure

Completed
NCT07330258

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

Recruiting
NCT06666322Phase 2

Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)

Recruiting
NCT06453187Not Applicable

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Enrolling By Invitation
NCT06014255Phase 2

Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer

Active Not Recruiting
NCT06855277Phase 3

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Recruiting
NCT07203534Not Applicable

ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period

Recruiting
NCT07723742Not Applicable

The Effect of Nutritional Education on Post-Arthroscopic Nutritional Status

Not Yet Recruiting
NCT06072482Phase 4

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Recruiting
NCT07018466Not Applicable

Tele-Exercise for MERP

Not Yet Recruiting
NCT04405401Phase 2

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Active Not Recruiting
NCT04607005Phase 3

Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
1,222